what happens when you stop taking bpc-157 Explained: Benefits, Safety & Oral vs Injectable Options BPC-157 vs TB-500 After Surgery

Studies suggest that AOD9604 does not bind the growth hormone receptor and does not activate the JAK2/STAT5 pathway, which accounts for the absence of growth-promoting or IGF-1-elevating effects observed in animal studies

10.1007/s12031-017-1006-x 72 IncandelaL.CesaroneM

I have found that injecting on the same side as the injury but not necessarily at the exact injury site produces excellent results

The second trial (NCT02240589) was completed in 2017, but results were inconclusive with the main limitation being small sample size (11 participants)

Foster, P

While the goal is to restore normal regulation, there is a theoretical risk of pushing the immune system in an unintended direction